돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1040184생성일: 2026년 10월 25일

Acetone → Methyl 4-{1,2-dihydroxy-1-[5-(3-methyl-5-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)-1,3-thiazol-2-yl]ethyl}benzoate

https://huagongshe.com/reaction/1040184

반응식

참여 물질

역할이름HCID투입량
반응물AcetoneHCID 180—
반응물Hydrochloric AcidHCID 313—
반응물WaterHCID 962—
반응물Methyl 4-{1-[5-(3-methyl-5-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)-1,3-thiazol-2-yl]ethenyl}benzoateHCID 67257947—
촉매Osmium TetroxideHCID 30318—
용매Ethyl AcetateHCID 8857—
용매Sodium SulfiteHCID 24437—
생성물Methyl 4-{1,2-dihydroxy-1-[5-(3-methyl-5-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)-1,3-thiazol-2-yl]ethyl}benzoateHCID 6743373965.5%

반응 단계

To a solution of the product from Step 1 (0.100 g, 0.201 mmol) and 4-methylmorpholine n-oxide (0.047 g, 0.403 mmol) in acetone (2.98 ml)/water (0.373 ml) was added osmium tetroxide (4% by weight in water, 0.158 ml, 0.020 mmol), and the mixture was stirred at room temperature. Upon completion by LCMS, the mixture was diluted with aqueous 10% Na2SO3 and EtOAc. The aqueous layer was acidified (pH 3-4) with 1 N HCl and extracted with 10% IPA/CHCl3. The combined organic layers were dried (Na2SO4), filtered and concentrated. A combination of chromatography on silica gel (Biotage 250 SNAP, 0-10% MeOH/DCM) and reverse phase HPLC (10-90% ACN/1-120) afforded methyl 4-{1,2-dihydroxy-1-[5-(3-methyl-5-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)-1,3-thiazol-2-yl]ethyl}benzoate (70 mg, 0.132 mmol, 65.5% yield). MS ESI: [M+H]+ m/z 531.1.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08551984B2
출처 데이터셋uspto-grants-2013_10
ORD IDord-279471e49d9447c29e17094ac7116102
출처 메모uspto-grants-2013_10